Increasing antibiotic resistance is one of the greatest threats to global human health. PathDiagnostix’s patent pending new diagnostic tests, based on peptide biomarkers, will enable clinicians to make accurate diagnoses and informed treatment decisions which will reduce the misuse of antibiotics.
Best in class.
Impact: Reduce the overuse of broad spectrum antibiotics.
GUV conctact: Lorna Fletcher